Cardioprotective effects of KR-30450, a novel K+(ATP) opener, and its major metabolite KR-30818 on isolated rat hearts

Japanese Journal of Pharmacology

Volumn 76, Issue 1, 1998, Pages 65-73

  Jung, Yi Sook ^a,b   Moon, Chang Hyun ^b   Cho, Tai Soon ^c   Yoo, Sung Eun ^a   Shin, Hwa Sup ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Cardioprotection; KR 30450 (SKP 450); KR 30818 (SKP 818); Lemakalim; Potassium channel activator

Indexed keywords

2 (1,3 DIOXOLAN 2 YL) 2 METHYL 6 NITRO 4 (2 OXO 1 PYRROLIDINYL) 2H 1 BENZOPYRAN; ADENOSINE TRIPHOSPHATE; DRUG METABOLITE; GLIBENCLAMIDE; KR 30818; LACTATE DEHYDROGENASE; LEMAKALIM; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE TIME EFFECT RELATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME RELEASE; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; RAT;

EID: 0031915218     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.65     Document Type: Article

References (29)

1. Cook NS: The pharmacology of potassium channels and their therapeutic applications. Trends Pharmacol Sci 9, 21-28 (1988)
2. + channels. Trends Pharmacol Sci 10, 431-435 (1989)
3. + channels: pharmacological properties, regulation, and therapeutic potential. Drug Dev Res 28, 95-127 (1993)
4. Evans JM and Stemp G: The discovery of cromakalim. Chem Britain 27, 439-442 (1991)
5. + channels? Trends Pharmacol Sci 14, 332-337 (1993)
6. + channels in cardiac ischemia: An endogenous mechanism for protection of the heart. Cardiovasc Drugs Ther 7, 527-537 (1993)
7. Grover GJ: Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia. Cardiovasc Res 28, 778-782 (1994)
8. Opie LH: Modulation of ischemia by regulation of the ATP-sensitive potassium channel. Cardiovasc Drugs Ther 7, 507-513 (1993)
9. ATP openers. J Cardiovasc Pharmacol 24, Suppl 4, S12-S17 (1994)
10. Lee BH, Yoo SE and Shin HS: Hemodynamic profile of SKP-450, a new potassium channel activator. J Cardiovasc Pharmacol (in press)
11. Shin HS, Seo HW, Yoo SE and Lee BH: Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310. Pharmacology (in press)
12. + channel. J Pharmacol Exp Ther 275, 807-812 (1995)
13. + channel. A comparison with pinacidil and lemakalim. Circ Res 69, 1152-1158 (1991)
14. Döring HJ: Differentiation of various cardiovascular drugs by means of specific rnyocardial and vascular load tests: Experiments at the isolated perfused heart. Arzneimittelforschung 39, 1535-1542 (1989)
15. Krzeminski T, Kurcok A, Kapustecki J, Kowalinski J, Slowinski Z and Brus R: A new concept of the isolated perfused heart preparation with on-line computerization data evaluation. J Pharmacol Methods 25, 95-110 (1991)
16. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA and Atwal KS: Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J Cardiovasc Pharmacol 25, 40-50 (1995)
17. Grover GJ, Dzwonczyk S, Parham CS and Sleph P: The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rats hearts and anesthetized dogs. Cardiovasc Drugs Ther 4, 465-474 (1990)
18. Grover GJ, Dzwonczy S, Parham CS and Sleph P: Pharmacological profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 16, 853-864 (1990)
19. Grover GJ, Dzwonczy S and Sleph PG: Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 53891. Eur J Pharmacol 191, 11-19 (1990)
20. Watts J and Maiorano L: Effects of diltiazem upon globally ischemic rat hearts. Eur J Pharmacol 138, 335 (1987)
21. Van der Laarse A, Holaar L, Van der Volk LJM: Release of alpha hydroxybutyrate from neonatal rat heart cell cultures exposed to anoxia and reoxygenation: comparison with impairment of structure and function of damaged cardiac cells. Cardiovasc Res 13, 345-353 (1979)
22. Wroblewski F and La Due JS: Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90, 210-213 (1955)
23. Gross GJ and Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70, 223-233 (1992)
24. + channel openers and natural cardioprotection. Trends Pharmacol Sci 23, 269 (1992)
25. Grover GJ, Sleph PG and Dzwonczyk S: Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 16, 853-864 (1990)
26. + channels in isolated cardiac myocytes. Biochem Biophys Res Commun 154, 620-625 (1988)
27. + current in cardiac muscle. Proc Natl Acad Sci USA 85, 8360-8364 (1988)
28. Grover GJ, McCullough JR, D'Alonzo AJ, Sargent CA and Atwal KS: Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. 25, 40-50 (1995)
29. ATP opener, in anesthetized dogs and isolated rat hearts. 52, 101-112 (1996)